等待开盘 09-20 09:30:00 美东时间
+0.010
+0.29%
NEW YORK-, Sept. 15, 2024 /PRNewswire/ -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Fulcrum Therapeutics, Inc. ("Fulcrum" or "the Compan...
09-16 04:00
In the preceding three months, 7 analysts have released ratings for Fulcrum The...
09-13 21:00
Fulcrum Therapeutics Shares Down 3% Premarket After 61% Drop in Previous Session
09-13 18:21
Fulcrum Therapeutics Inc : H.c. Wainwright Cuts to Neutral From Buy
09-13 18:14
Cantor Fitzgerald analyst Kristen Kluska downgrades Fulcrum Therapeutics (NASDAQ:FULC) from Overweight to Neutral.
09-12 23:19
CSBR: 59% | Champions Oncology shares are trading higher after the company reported better-than-expected Q1 financial results. Also, Craig-Hallum upgraded the stock from Hold to Buy and maintained its $6 price
09-12 20:08
Fulcrum Therapeutics (NASDAQ:FULC) lost ~70% premarket Thursday after its lead program for protein kinase inhibitor, losmapimod, in-licensed from GSK (NYSE:GSK), failed to reach main goals in patients...
09-12 19:13
新浪财经ESG评级中心提供包括资讯、报告、培训、咨询等在内的14项ESG服务,助力上市公司传播ESG理念,提升ESG可持续发展表现。点击查看【 ESG评级中...
08-28 07:00
成分股Phathom Pharma收涨12.77%领跑,Verve Therapeutics涨8.02%,Vericel也涨7.25%;Pacific Bio...
08-28 04:54
Fulcrum Therapeutics Strengthens Leadership Team With the Appointments of Isabe...
08-19 19:00